Main Menu

Lewis H. Lazarus Discusses McKesson Corporation Derivative Settlement of Opioid Litigation

News & Media Mentions

February 20, 2020

Lewis H. Lazarus, a partner in the Morris James LLP Corporate and Commercial Litigation Group, discusses with Agenda a recent settlement in a lawsuit accusing directors of McKesson Corporation of failing under Delaware law properly to oversee the company's distribution of opioids. 

Lewis commented, "Governance reforms attached to litigation settlements are far from rare and are viewed by boards as a way to end the burden, expense and distraction associated with litigation." Such reforms tend to be tailored to the allegations, he adds, pointing out that, in the case of McKesson, the complaint emphasized that, while on notice of opioid concerns because of a 2008 settlement, issues continued with some of the same directors on the board.

View full article here. (Subscription Required)

Back to Page